Measuring the impact of monoclonal antibody therapies

Measuring the impact of monoclonal antibody therapies

ObjectiveMonoclonal antibody (Mab) treatments have significantly improved the quality and quantity of life, but they are some of the most expensive treatments, resulting in a degree of hesitancy to introduce new Mab agents. A system for estimating the effect of Mab drugs, in general, would optimally...

Full description

Bibliographic Details
Main Authors: Ka Keat Lim, Kenrick Ng, Sathiyaa Balachandran, Mark D. Russell, Amy Boalch, Alasdair Sinclair, Bolaji Coker, Krishna Vinnakota, Rashid Mansoor, Abdel Douiri, Lara V. Marks, Steven Sacks
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-11-01
Series:Frontiers in Medicine
Subjects:
monoclonal antibodies
real world data (RWD)
systematic literature review
meta-analysis
cost benefit evaluation
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2023.1256712/full

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2023.1256712/full

Similar Items